about
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Constr...
Read More
32.07
-0.55
(-1.69%)
76,876.6
XNAS Volume
XNAS 14 May, 2026 1:52 PM (EDT)
Board Meeting
The next board meeting for Neurogene Inc is on 15 May 2026 for the purpose of Neurogene Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Neurogene Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..